CA
NZ
UK
AU
IND
US
● Seventeen of those patients had an objective response to treatment.
● Mesoblast's American depositary shares climbed to $15.63 among theNasdaqComposite's biggest gainers.
● Healthcare costs and preneed selling costs both increased in the quarter.
● Health care was the best-performing group in the S&P 500.
● The company makes CT, MRI, X-ray and ultrasound equipment.
● The company raised its full-year EPS guidance.
● The company makes Invisalign clear aligners.
Key Highlights● Biogen posted a GAAP loss driven by acquisition charges.● Revenue grew during the quarter.● The company raised the low end of its full-year guidance.● Biogen continues working to offset declining older drug sales.Biogen grew revenue and raised the low end of its …
● The company guided Q4 sales below the prior-year level.
● Shares were down more sharply early in the session than at the close.
Please wait processing your request...